Introduction
Down syndrome (DS), a complex disease resulting from the presence and expression of three copies of genes located on chromosome 21, is the most frequent genetic cause of mental retardation, and the most common chromosomal disorder in newborns with a prevalence of 1/700 -1/1000 live births [1] and 1/150 conceptions [2] . In 95% of DS cases, trisomy is caused by a meiotic error occurring at maternal meiosis I or II [3, 4] . In spite of high prevalence, medical interest and social impact, the cellular and molecular mechanisms underlying meiotic non-disjunction are not yet understood. A compromised microcirculation has been hypothesized. However, only one risk factor for maternal non-disjunction has been definitive and well-established -maternal age [5] [6] [7] . An association has also been found between maternal smoking combined with oral contraceptives use and DS [8, 9] . The primary prevention of the disease will be based on identification of genetic or environmental factors influencing maternal non-disjunction.
In 1999, a study reporting an increased maternal risk of DS in mothers carrying the methylenetetrahydrofolate reductase (MTHFR) gene polymorphism associated with elevated plasma homocysteine and low folate status was published [10] . Variants in folate, Vitamin B12 and homocysteine metabolism coding genes have been previously reported to increase the risk of birth defects, aging-related chronic diseases, vascular diseases and male infertility, and they have been associated with an increased occurrence of neural tube defects [11, 12] . The supposed pathogenetic mechanism involved in non-disjunction related to DS was described as follows: folate deficiency will provoke DNA hypomethylation and DNA strand breaks, which in turn cause chromosomal instability and abnormal segregation [13, 14] , the folate deficiency itself being under the influence of polymorphisms in the folate metabolism genes. However, the genetic background could be disputed due to the lack of familial aggregation evidence and the lack of interethnic variability in DS frequency.
Studies which have investigated polymorphisms in the MTHFR gene and other variants in genes involving folate metabolism were published, but with controversial results. In order to avoid these contradictions and uncertainties regarding false positive or false negative associations resulting from individual association studies, and to ensure certainty in statistical analyses enhancing the size of the examined sample and the statistical power of a study, we performed a meta-analysis of case-control studies on genetic polymorphisms involved in the folate metabolism investigated so far in mothers of DS children.
Such an analysis would permit to identify the folate metabolism genes as the risk factors of maternal nondisjunction; DS would thus become one of genetic disorders preventable by environmental influence, in this specific case by folates intake in reproductive age [15, 16] .
Material and Methods

Data sources
The electronic PubMed MEDLINE (http://www. pubmed. gov) database was searched up until 1 st July 2008 for the studies on genetic polymorphisms in DS. All case-control studies in all languages evaluating any candidate gene in trisomy 21-related non-disjunction were registered. Our investigation was based on the medical subject headings terms: genetic polymorphisms and DS. Besides association studies, review articles were also considered. To avoid a possible loss of any relevant article, an additional control was performed through the references cited in identified articles, and through the link "related articles" offered in the PubMed database, and through the references of review articles. Finally, a conclusive search was performed using the key words: 
Study selection
The search through the key words DS and polymorphism, identified 295 studies. Among them, the studies of genetic variants in maternal non-disjunction, i.e., the genetic variants in mothers of DS children were selected. Only the studies analyzing the association between maternal non-disjunction in trisomy 21 and polymorphisms in the folate metabolism genes MTHFR, MTHFD, MTRR, MTR, RFC1 and CBS, were further analyzed. The studies had to be retrospective case-control studies with genotype frequencies reported. The authors of a study reporting allele frequencies without genotype frequencies were contacted to obtain missing data; since no answer was obtained, this study was not included in the analysis. Additionally, abstracts, letters, editorials, reviews, and congress communications were excluded. The studies by the same author were controlled for a possible overlapping of included patients: one pair of such articles was found, and the study with a higher number of cases was selected [17, 18] . Only two articles not written in English were found [19, 20] . However, the article written in Portuguese was later published in English, and thus included [21] . One previous meta-analysis was found [22] . Our meta-analysis was performed only on the polymorphisms investigated in at least three studies.
Data extraction
Of the 16 case control articles analyzing seven polymorphisms in six folate metabolism genes, we performed a systematic review of 16 studies on the MTHFR/677C>T polymorphism, 10 studies on the MTHFR/1298A>C polymorphism, 6 studies on the MTRR/66A>G polymorphism, 4 studies on the MTR/2756A>G polymorphism, 4 studies on the RFC1/80A>G polymorphism, and 3 studies on the CBS/844ins68 polymorphism. There was only one study investigating the MTHFD polymorphism. For each analysis the following data were extracted: author, country and year of publication, patients' and controls' ethnicity and continent, patients' and controls' mean age if given, and statistical method used/statistical results of the study. For each polymorphism/DS risk, even if already performed the odds ratio (OR) was calculated again, under both assumptions: supposed effect of polymorphism if dominant, and the effect if recessive.
Statistical analysis
Data were analyzed statistically by R programming language (meta, rmeta and HardyWeinberg packages) [http://www.r-project.org]. For each genetic variant study, individual and pooled odds ratio and associated 95% CI were calculated, the fixed-effects model (Mantel-Haenszel method) and random-effects model (DerSimonian-Laird method) were used. The p-value less than 0.05 was set as significant. Tests for heterogeneity were performed for each meta-analysis (Q score): a p-value less than 0.05 was considered to indicate that heterogeneity was likely. For the assessment of publication bias the funnel plot and the Egger regression asymmetry test was used.
Results
The genetic associations between polymorphism genotypes of MTHFR, MTRR, MTR, RFC1, and CBS genes and maternal risk for DS offspring were examined.
For each gene/polymorphism, more than 3 studies reporting case-control analyses were found for MTHFR/ C677T, MTHFR/A1298C, MTRR/A66G, MTR/A2756G, RFC1/A80G, and CBS/844ins68, and they were 16,10,6,4,4,3, respectively. These studies were included in our review.
All 43 analyses reported genotype frequencies, enabling the statistical analysis for all polymorphisms under both -dominant and recessive genetic model. The genotype distribution among control subjects in each study did not deviate from the expected Hardy-Weinberg equilibrium, except for 4 studies as shown in Tables 2-4. As the genotype distribution among the same control subjects but on other investigated polymorphisms did not deviate from the expected equilibrium, it was concluded that the disequilibrium found was not due to population characteristics, but as a consequence of genotyping errors; these studies have been also included in metaanalysis.
All 43 studies clearly defined the inclusion criteria in both -case and control groups. However, in two studies, besides mothers of DS children, pregnant women carrying DS fetuses were also included. Most studies also defined the exclusion criteria for controls. The majority of studies reported the patients' ages.
The summary OR demonstrated a statistically significant increased risk of having a child with DS in mothers who were homozygous and/or heterozygous carriers of the mutant allele in the MTHFR/C677T gene polymorphism; in mothers who were homozygous carriers of the mutant allele in the MTRR/A66G gene polymorphism. Borderline statistical significance was achieved for homozygous and heterozygous carriers of the mutant allele in the MTRR/A66G gene polymorphism. In mothers who were homozygous and/or heterozygous carriers of the mutant allele of the MTHFR/A1298C polymorphism and in mothers who were homozygous and/or heterozygous carriers of the mutant allele in the RFC1/A80G gene polymorphism the increased risk was found but without statistical significance. No statistical association with the risk was demonstrated for carriers of mutant alleles in polymorphisms of the MTR and the CBS genes ( Table 1 Summary of results of the metaanalysis).
MTHFR/C677T polymorphism in DS mothers
The characteristics of 16 analyses on the C677T polymorphism in the MTHFR gene and the risk of giving birth to a DS child are summarized in Table 2 . These studies involved 1545 patients and 2052 controls. All studies reported genotype numbers separately ( al. However, the summary OR under the random effect assumption that takes into account the intra-study and inter-study variability resulted in a similar overall OR estimate of 1.4 (95% CI 1.16, 1.69). The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.20), suggesting a low probability of publication bias. For individuals homozygous for the T allele compared with C allele carriers (CT plus CC) (recessive genetic model), the summary odds ratio under the fixed-effects model was 1.35 (95% CI 1.09, 1.67). The random-effects model revealed comparable result OR= 1.35 (1.02, 1.78). No heterogeneity was detected in the dataset: Q 2 (15)=22.35 (p=0.10). The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.33), suggesting a low probability of publication bias (Figure 1 ).
MTHFR/A1298C polymorphism in DS mothers
The characteristics of 10 analyses on the A1298C polymorphism in the MTHFR gene and the risk of giving birth to a DS child are summarized in Table 3 . These studies involved 1007 patients and 1318 controls. All studies reported genotype numbers separately ( The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.60), suggesting a low probability of publication bias (Figure 2 ).
MTRR/A66G polymorphism in DS mothers
The characteristics of 6 analyses on the A66G polymorphism in the MTRR gene and the risk of giving birth to a DS child are summarized in Table 4 . These studies involved 623 patients and 936 controls. All studies reported genotype numbers separately ( The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.16), suggesting a low probability of publication bias. For individuals homozygous for the G allele compared with A allele carriers (AG plus AA) (recessive genetic model), the summary OR under the fixed-effects model was 1.52 (95% CI 1.2, 1.93). The random-effects model revealed a comparable result OR=1.57 (1.06, 2.31). Due to the studies by Wang et al and Scala et al. the heterogeneity was detected to be of medium magnitude: Q(5)=12.54 (p=0.03); I 2 =60.1%,. The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.35), suggesting a low probability of publication bias (Figure 3 ).
MTR/A2756G polymorphism in DS mothers
The characteristics of 4 analyses on the A2756G polymorphism in the MTR gene and the risk of giving birth to a DS child are summarized in reported the number of genotypes separately ( Table 5 ). The summary OR estimate under the fixed-effect model for GG homozygous plus AG heterozygous individuals compared to homozygous carriers of the A wild type allele was 1.03 (95% CI 0.79, 1.35). The summary OR under the random effect assumption resulted in a similar overall estimate -1.04 (95% CI 0.8, 1.35). No heterogeneity was detected: Q(3)=2.27 (p=0.52).The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.45), suggesting a low probability of publication bias.
For individuals homozygous for the G allele compared to A allele carriers (AG plus AA) (recessive genetic model), the summary OR under the fixed-effects model was 1.43 (95% CI 0.66, 3.11). The random-effects model revealed a comparable result OR=1.43 (0.65, 3.13).
No heterogeneity was detected in the present dataset: Q(3)=0.25 (p=0.97). The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.90), suggesting a low probability of publication bias. Table 6 . Characteristics of studies on RFC1 80 A>G polymorphisms in mothers of DS children.
RFC1/A80G polymorphism in DS mothers
The characteristics of 4 analyses on the A80G polymorphism in the RFC1 gene and the risk of giving birth to a DS child are summarized in Table 6 . These studies involved 354 patients and 644 controls, and reported the number of genotypes separately ( Table 6 ). The summary OR estimate under the fixed-effects model for GG homozygous plus AG heterozygous individuals compared to homozygous carriers of A wild type allele was 1.32 (95% CI 0.96, 1.81). The summary OR under the random effect assumption resulted in a similar overall estimate -1.32 (95% CI 0.95, 1.82). No heterogeneity was detected: Q(3)=2.53 (p=0.47). The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.69), suggesting a low probability of publication bias.
For individuals homozygous for the G allele compared with A allele carriers (AG plus AA) (recessive genetic model), the summary OR under the fixed-effects model was 1.23 (95% CI 0.91, 1.67). The random-effects model revealed a comparable result OR=1.24 (0.92, 1.68).
No heterogeneity was detected in the present dataset: Q(3)=2.87 (p=0.41). The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.37), suggesting a low probability of publication bias.
CBS/844ins68/ polymorphism in DS mothers
The characteristics of 3 analyses on the 844ins68 polymorphism in the CBS gene and the risk of giving birth to a DS child are summarized in Table 7 . These studies involved 367 patients and 542 controls, and they all reported genotype numbers separately ( Table 7) . The summary OR estimate under the fixed-effects model for homozygous plus heterozygous carriers of the insertion compared to homozygous carriers of wild type (deletion) allele was 0.97 (95% CI 0.67, 1.4). The summary OR under the random-effects assumption resulted in a similar overall estimate -0.97 (95% CI 0.67, 1.4). In the dataset there was no heterogeneity: Q(2)=1.09 (p=0.58). The distribution of the OR in relation to its standard error in the funnel plot was symmetrical, and the Egger test result was not significant (p=0.05), suggesting a low probability of publication bias.
The recessive genetic model was not calculated because of a small number of individuals homozygous for the mutant (insertion) allele both among cases and controls.
Discussion
It has been almost 10 years since the first account on the role of a polymorphism in a gene involved in folate metabolism and its association with maternal risk of DS offspring was published [10] . The study had great impact as it proposed the genetic susceptibility to meiotic nondisjunction. Subsequent studies on different genes involved in the folate metabolism reported contrasting results. These discrepancies can be explained by significant differences in study design, differences in gene-nutrient (folate and B 12 ) interaction, variable allele frequency of polymorphism in function of ethnic and geographic origin of study groups, and missing information on the effect of polymorphism on the survival of trisomic fetuses. Populations with high folate intake in their diet (Mediterraneans) might overcome their folate deficiency due to genetic causes. Therefore, the studies in these populations did not recognize an association between polymorphisms in the folate metabolism genes and maternal susceptibility to DS offspring [12] . Recently, a meta-analysis has been published, rejecting the association of polymorphisms in two folate metabolism genes and maternal risk for DS [22] . However, in light of new and additional data [18, 20, [23] [24] [25] on the same subject, we performed a meta-analysis not only on these two genes, but on six polymorphisms in five folate metabolism genes.
Our meta-analysis shows that women carriers of the T allele of the C677T/MTHFR polymorphism are at a 40% or at a 35% increased risk of giving birth to a child with trisomy 21, when the polymorphism is considered under the dominant or recessive genetic model, respectively. Women carriers of the G allele of the A66G/MTRR polymorphism are at a 57% increased risk of giving birth to a child with trisomy 21. when the polymorphism is considered under the recessive genetic model. A similar result was obtained if the polymorphism was considered under the dominant model, but with borderline statistical significance. The results of the A1298C/MTHFR and A80G/RFC1 polymorphisms showed an increased risk for the carriers of mutant alleles, but failed to reach Table 7 . Characteristics of studies on CBS 844ins68 polymorphisms in mothers of DS children.
statistical significance. Finally, no increase in risk was demonstrated for carriers of risk alleles of the A2756G/ MTR and 844ins68/CBS polymorphisms. It has been hypothesized that an abnormal folate metabolism could result in aberrant DNA methylation which might increase the likelihood of meiotic nondisjunction [10] . The underlying pathogenetic processes through which the genetic polymorphisms could influence the activity of the folate enzymes and contribute to the development of meiotic nondisjunction have been established. Folates are cofactor carriers and donors of one-carbon units. The folate cycle is involved in two main physiological processes. One of which is the synthesis of purines and pyrimidines, and the other is the methylation associated with the methionine cycle. These two pathways are regulated by two reactions; one is the re-methylation of homocysteine to methionine, which is the precursor of S-adenosylmethionine, the most important methyl donor for DNA, RNA, protein and lipid methylation processes, and the other is the transsulfuration pathway, which, through CBS, produces cysteine and glutathione, removing homocysteine from the cycle [17, 26] . Transmethylation of homocysteine to methionine is influenced by three key enzymes of the folate metabolism. The MTHFR is a flavoprotein which catalyzes the synthesis of 5-methyl-H 4 -folate, the methyl donor for the B 12 -dependent remethylation of homocysteine to originate methionine through the methionine synthase reaction. MTR catalyzes the methyl transfer from 5-methyl-H 4 -folate to homocysteine, i.e., the remethylation of homocysteine to methionine. MTRR maintains MTR in its functional state [18] .
Outside of the aforementioned pathways, the folate metabolism is also influenced by the RFC-1 enzyme which participates in the internalization of 5-methyl-H 4 -folate into cells. Two polymorphisms have been described in the MTHFR gene: the T variant at nucleotide 677 (MTHFR/ C677T) which reduces enzyme activity [27] , and the C variant at nucleotide 1298 (MTHFR/A1298C) causing a decreased MTHFR activity, which is more pronounced in the homozygous than heterozygous state [28] . Both polymorphisms may affect the extent of DNA methylation [29] . The variants reduce the MTHFR activity and cause an increased need of folic acid to allow the remethylation of homocysteine to methionine [18] .
A polymorphism A2756G in the MTR gene has been described and associated with aberrant methylation in the homozygous state [30] . The A66G polymorphism in the MTRR gene has been described, but with unknown effects on the enzyme activity. The 844ins68 polymorphism in the CBS enzyme gene may decrease homocysteine levels; the variant is carried by nearly 10% of the general population [31] . In the RFC-1 gene the polymorphism A80G has been described to lead to a nonsignificantly decreased plasma folate levels [32] .
It has been hypothesized that a relative deficiency of folate metabolism, also caused by the aforementioned genetic alterations, might lead to DNA hypomethylation, increased occurrence of DNA strand breaks, disrupted chromosome recombination and aberrant chromosome segregation [10] . The stability of chromosomal centromeric region is known to be dependant on specific DNA methylation patterns, normally recognized by methyl-sensitive stabilizing proteins. Perturbations in the centromeric structure caused by DNA hypomethylation could interrupt normal segregation of chromosomes during cell division, leading to aneuploidies [33] . Furthermore, experimental evidence shows that chemical agents that inhibit DNA methylation induce chromosomal instability and aneuploidies [34] .
The results of our analysis should be firstly commented by taking in consideration the biological rationale, i.e., the pathogenetic processes by which the investigated polymorphisms contribute to altered folate metabolism. Interestingly, in our meta-analysis the two polymorphisms in the MTHFR gene produced discordant results: the MTHFR/C677T polymorphism showed a strong association with maternal risk for DS offspring, whereas the MTHFR/A1298C polymorphism failed to reach the statistical significance. This observation could be paralleled to previous functional investigations of the two polymorphisms which demonstrated greater functional effects of MTHFR/C677T variants on the MTHFR activity than did the MTHFR/A1298C polymorphism [27, 28] . On the other hand, the results of functional studies in other polymorphisms included in our meta-analysis were incomplete, not allowing a correlation of our results to the pathogenetic mechanisms involved.
Additionally, our analyses should be commented from the methodological point of view. Firstly, our comprehensive search likely excluded the selection bias; only one study was excluded for not being written in English. Secondly, the publication bias was excluded by statistical analyses (Egger test, funnel plots). Thirdly, in our study the statistical power was increased in comparison with individual reports as the number of investigated patients and controls was significantly greater than that of individual studies. Only the studies with the genotype frequencies were considered, studies reporting only allele frequencies were not considered; statistics were performed under alternative genetic models. Fourthly, although clinical evaluation of the papers in search for heterogeneity revealed no interstudy variability in patients' characteristics, disease characteristics, and diagnostic criteria, the statistical analyses demonstrated heterogeneity in the MTHFR/ C677T meta-analysis, if under the dominant genetic model, in the MTHFR/A1298C meta-analysis, if under the recessive model, and in the MTRR/A66G polymorphism, this one under both models. Therefore, only the results of summary OR obtained using the random effects model were considered. We presume that population differences may be sources of heterogeneity. Finally, four studies with deviation from Hardy-Weinberg equilibrium were also included in meta-analyses; as the genotype distribution among the same control subjects but on other investigated polymorphisms, did not deviate from the expected equilibrium, we assumed that the disequilibrium was not due to population characteristics, but a consequence of genotyping errors.
In conclusion, we conducted this meta-analysis with the aim of revoking interest in the folate metabolism alterations as an influencing factor to trisomy 21 offspring. Our results have confirmed our assumption that polymorphisms in the folate metabolism genes may be involved in DS etiology. No single polymorphism has been identified as having a major effect, however, several genes, each with a moderate effect could play a role.
Our results imply the potential effect of folate supplementation in women of reproductive age in order to prevent negative effects of genetic alterations previously described, and also their consequences. The observation that there is no decrease in DS incidence since the introduction of folate supplementation for other reasons could be argued by the notion that the effect should be achieved in the subsequent generation: in daughters of the women that received supplementation [16] . Taking into consideration of the effect of polymorphisms on fetal viability, the lack of association of folate genetic polymorphisms with DS offspring in some studies should be reexamined.
Further genetic studies, based on more comprehensive genetic approaches, such as haplotype analyses of multiple polymorphisms and the combined effect of polymorphisms in several folate genes are required. Interestingly, we have noticed a lack of association studies of folate metabolism genes in populations of sub-Saharan African origins and different East Asian populations. Studies on these populations could help overcome the gap in the current knowledge of the role of the folate metabolism genes in maternal risk of DS offspring.
